SOM Biotech participated in the 10th Drug Discovery Innovation Programme that took place on November 28th -29th- in Barcelona, Spain. Luca Signorile – Computational Chemist of SOM Biotech –performed the presentation on the topic “Re-Discovering Drugs: Advantages, Perspectives, and the role of AI.” During his speech, he gave an insight into the computational side of…

SOM Biotech has participated in the “Clinical Trials Europe 2019” conference, that took place on November 19th -21st- in Barcelona, Spain. The “Clinical Trials Europe 2019”, one of the leading platforms to build partnerships to develop clinical trials, attracts a wide range of innovative research centers and business development teams from biotech and pharma companies.…

SOM Biotech participated in the World Orphan Drug Congress Europe 2019 on November 12th -14th- in Barcelona, Spain, where the company was a Showcase Sponsor. Raul Insa – CEO of SOM Biotech – presented “Case study: Systematic drug re-innovation and clinical evidence in orphan diseases”. SOM Biotech shared its latest findings in drug discovery and…

Gal·la Pericot, R&D Manager at SOM Biotech, attended the European Conference on Recent Advances in Lysosomal Diseases, which took place on 24-25 October 2019 in London, UK. The main objective of the conference was sharing of innovative knowledge on the development of new therapeutic modalities for treating disorders linked to the lysosomal storage in the cells,…

SOM Biotech will participate in the 25th Annual International Partnering Conference “Bio-Europe” on November 10th -13th- in Hamburg, Germany. The conference, Europe´s largest life science partnering venue, is one of the most relevant events to meet with world-leading life science partners, investors, and industry experts. Raul Insa – CEO of SOM Biotech – and Maria…

Luca Signorile, the Senior Computational Chemist at SOM Biotech, participated in the 19th Annual Schrödinger European User Group Meeting, that took place in Berlin on September 25th-27th. The Meeting aimed at illustrating how the capabilities of the Schrödinger software can be efficiently applied to drug discovery to increase research productivity. Science and Technology are the…